Enliven Therapeutics, Inc. (ELVN)

48.19 -0.68 (-1.39%) USD  |  NASDAQ  |  Sep 22, 16:00
48.18 -0.02 (-0.03%) After-Hours: 20:00
More

Enliven Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for ELVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Operating Income (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
December 31, 2021 --
Date Value
December 31, 2020 --
December 31, 2019 --
December 31, 2018 --
December 31, 2017 --

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Definium Therapeutics, Inc. Upgrade
Cocrystal Pharma, Inc. Upgrade
CNBX Pharmaceuticals, Inc. Upgrade
GB Sciences, Inc. --
Arvinas, Inc. Upgrade